FINKELSTEIN J J (President and CEO) reported 1 transaction at REGENERX BIOPHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 7/9/2018ACC: 0000914190-18-000281
DirectorOfficer· President and CEO
Since Jul 2018
0.00
Net shares
Net seller
$6.3K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
104.46K acquired · 104.46K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+104.46K
Price / share
$0.06
Trade value
$6.27K
% of position
6.8%
7/5/2018
1.53M→1.64M
Total
Net shares
+104.46K
Net value
$6.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/5/2018 | C · Conversion | +104.46K | $0.06 | $6.27K | 6.8% | 1.53M | 1.64M |
| Total | +104.46K | $6.27K | ||||||
Derivative Transactions1
Convertible Promissory Note (right to buy)
Direct
Converts to
Common Stock
104.46K shares
Shares
−104.46K
Strike price
.06
Held after
0.00
Exercisable
—
7/5/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Convertible Promissory Note (right to buy) Direct | Common Stock104.46K shares | 7/5/2018 | C · Conversion | −104.46K | .06 | — | 0.00 |